Skip to main content

Table 1 Patient characteristics and number of scans performed

From: Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy

  

Number (%)

Age

Years ± SD

63.0 ± 9.6

Gender

Female

23 (52.3%)

Primary tumour

Small intestine

28 (63.6%)

Pancreas

11 (25.0%)

Lung

3 (6.8%)

Unknown

2 (4.5%)

Grade

1

26 (59.1%)

2

16 (36.4%)

3

2 (4.5%)

Anatomical imaging

Baseline

#

44 (100%)

3 months

#

42 (95.5%)

Time [range]

2 months [1–5]

9 months

#

39 (88.5%)

Time [range]

9 months [5–12]

[68Ga]Ga-DOTA-TATE PET/CT

Baseline

#

44 (100%)

3 months

#

41 (93.3%)

Time [range]

3 months [2, 3]

9 months

#

27 (61.4%)

Time [range]

9 months [6–12]

CgA

Baseline

#

44 (100%)

3 months

#

42 (95%)

Time [range]

2.5 months [1–6]

9 months

#

39 (89%)

Time [range]

9 months [6–12]